Telix Pharmaceuticals | TLX - Cash And Equivalent

Stock Price
14.37
Daily Change
0.77 5.66%
Monthly
-14.92%
Yearly
-20.83%
Q3 Forecast
13.73

Telix Pharmaceuticals reported AUD710.35M in Cash and Equivalent for its fiscal semester ending in December of 2024.



Financials
Stock Price AUD
Assets AUD 1.52B
Cash and Equivalent AUD 710.35M
Cost of Sales AUD 148.66M
Current Assets AUD 918.56M
Current Liabilities AUD 330.91M
Debt AUD 581.45M
EBIT AUD 37.44M
EBITDA AUD 33.24M
EPS Earnings Per Share AUD 0.28
Equity Capital and Reserves AUD 568.21M
Gross Profit on Sales AUD 129.12M
Interest Expense on Debt AUD 3.39M
Interest Income AUD 1.37M
Loan Capital AUD 551.82M
Market Capitalization AUD 4.41B
Net Income AUD 10.13M
Operating Expenses AUD 191.9M
Operating Profit AUD 17.72M
Ordinary Share Capital AUD 334.73M
PE Price to Earnings AUD 164.4
Pre-Tax Profit AUD 10.69M
Sales Revenues AUD 309.72M
Selling and Administration Expenses AUD 55.91M
Stock AUD 38.14M
Trade Creditors AUD 68.7M
Trade Debtors AUD 158.99M

Cash And Equivalent Change Date
Cochlear AUD 383.1M 130.5M Dec/2024
CSL USD 1.52B 133M Dec/2024
Integral Diagnostics AUD 17.99M 15.86M Dec/2023
Mayne Pharma AUD 110.07M 838K Jun/2024
Medical Developments International AUD 17.62M 7.88M Dec/2024
Mesoblast USD 62.56M 14.58M Jun/2024
Neuren Pharmaceuticals AUD 3.15M 582K Dec/2024
Pacific Edge NZD 22.57M 637K Mar/2025
Paradigm Biopharmaceuticals AUD 17.82M 15.73M Jun/2024
Polynovo AUD 45.91M 330K Jun/2024
PYC Therapeutics AUD 49.25M 17.62M Dec/2024
Ramsay Health Care AUD 341.1M 321.2M Dec/2024
ResMed USD 1.21B 687.51M Jun/2025
Sonic Healthcare AUD 645M 25.39M Jun/2024